The Department of Health today (October 11) endorsed Roche Hong Kong Limited (Roche) , a licensed drug wholesaler, to conduct a voluntary recall of six registered pharmaceutical products namely Rocephin for Inj 250mg IM (HK-20182), Rocephin for Inj 500mg IM (HK-20187), Rocephin for Inj 500mg IV (HK-20188), Rocephin for Inj 1g IV (HK-20190), Rocephin for Inj 1g IM (HK-20192) and Rocephin for Inj 250mg IV (HK-52844) because of a stability issue.   Close